Publications 2019

Mélanie Donnette, Caroline Solas, Madeleine Giocanti, Geoffroy Venton, Laure Farnault, et al.. Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients. Journal of Chromatography B Biomedical Sciences and Applications, 2019, 1126-1127, pp.121770. ⟨10.1016/j.jchromb.2019.121770⟩. ⟨hal-02483206⟩
Gianluca Civenni, Roberto Bosotti, Andrea Timpanaro, Ramiro Vàzquez, Jessica Merulla, et al.. Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer. Cell Metabolism, 2019, 30 (2), pp.303-318.e6. ⟨10.1016/j.cmet.2019.05.004⟩. ⟨hal-02483099⟩
Crescent Gbeto, Sylvie Quaranta, Roxane Mari, Raphaelle Fanciullino, Catherine Roche, et al.. Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency. Pharmacogenomics, 2019, 20 (13), pp.931-938. ⟨10.2217/pgs-2019-0028⟩. ⟨hal-02483216⟩
Sébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, Didier Debieuvre, Jean-Philippe Merlio, et al.. Clinical outcomes of non–small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study. European Journal of Cancer, 2019, 116, pp.86-97. ⟨10.1016/j.ejca.2019.04.016⟩. ⟨hal-02483130⟩
Arnaud Jeanson, Pascale Tomasini, Maxime Souquet-Bressand, Nicolas Brandone, Mohamed Boucekine, et al.. Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 2019, 14 (6), pp.1095-1101. ⟨10.1016/j.jtho.2019.01.011⟩. ⟨hal-02104417⟩